Summary
CME Group Inc. (CME) filed an 8-K on July 22, 2003, to report its financial results for the second quarter of 2003. This filing includes a press release providing details on the company's performance during the period. Investors should note that the information furnished under Regulation FD disclosure is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated by reference into other SEC filings, unless specifically stated. The core of this report is the press release, which serves as the primary source for CME's Q2 2003 financial performance. Investors looking for details on revenue, profitability, and operational highlights from this quarter will find them within the attached exhibit.
Key Highlights
- 1CME Group Inc. (CME) filed an 8-K report on July 22, 2003.
- 2The report's primary purpose is to disclose financial results for the second quarter of 2003.
- 3An attached press release (Exhibit 99.1) contains the detailed Q2 2003 financial results.
- 4The filing is made under Regulation FD Disclosure (Item 9).
- 5Information furnished under Item 9 is not considered 'filed' for certain SEC purposes.
- 6The press release dated July 22, 2003, is incorporated by reference as Exhibit 99.1.
- 7Kathleen M. Cronin, Corporate Secretary, signed the report on behalf of CME Group Inc.